Rick Hamler

Rick Hamler is an experienced bioanalytical scientist with a strong background in mass spectrometry and method development. Currently serving as Associate Director of Bioanalysis at QPS Holdings, LLC since December 2020, Rick specializes in LC-HRMS quantitation of therapeutic mRNA oligonucleotide therapeutics. Prior to this role, Rick held various positions at Amicus Therapeutics, including Associate Director of Bioanalytical Mass Spectrometry, focusing on proteomic and glycomic characterization. Rick's earlier experience includes roles at Galleon Pharmaceuticals and Adolor Corporation, where Rick contributed to the quantitation and metabolite identification of small molecules. Rick began a career in research at QPS, LLC, and holds a PhD in Analytical Chemistry from the University of Michigan.